
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1047 | 922 | 1047 | 834 | 1149 | 1762 |
Fund Return | 4.66% | -7.77% | 4.66% | -5.88% | 2.82% | 5.83% |
Place in category | 513 | 702 | 513 | 551 | 355 | 80 |
% in Category | 78 | 97 | 78 | 94 | 75 | 27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
B Multistock Swiss Stock Fund CHF A | 44.03M | 2.73 | -4.11 | 6.66 | ||
B Multistock Swiss Stock Fund CHF B | 114.96M | 2.73 | -4.11 | 6.66 | ||
B Multistock Swiss Stock Fund CHF C | 16.24M | 3.51 | -3.39 | 7.46 | ||
Multiflex S Carnot Efficient Energc | 100.89M | 5.19 | 0.91 | 3.44 | ||
Popso Suisse Investment Fund S Glob | 92.69M | 2.14 | -0.41 | 1.89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.71B | 11.69 | 5.78 | 7.07 | ||
Pictet CH Institutional Swiss EquiZ | 2.27B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 2.27B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquZD | 2.27B | 10.09 | 3.81 | 7.80 | ||
Pictet CH Institutional Swiss EquiP | 2.27B | 8.84 | 1.85 | 7.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 6.47 | 96.31 | +0.64% | |
Nestle | CH0038863350 | 6.21 | 89.04 | +0.50% | |
Roche Holding Participation | CH0012032048 | 6.15 | 307.30 | +3.64% | |
Lonza Group | CH0013841017 | 4.93 | 539.20 | +0.97% | |
Geberit | CH0030170408 | 4.85 | 577.00 | +0.17% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review